Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (CRVS)

CUSIP: 221015100

Q1 2016 13F Holders as of 31 Mar 2016

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
91,091,040
Total 13F shares
13,758,120
Share change
+13,643,120
Total reported value
$199,086,000
Price per share
$14.50
Number of holders
31
Value change
+$197,418,000
Number of buys
30

Quarterly Holders Quick Answers

What is CUSIP 221015100?
CUSIP 221015100 identifies CRVS - Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of CRVS - Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

Institutional Holders of Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (CRVS) as of Q1 2016

As of 31 Mar 2016, Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (CRVS) was held by 31 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 13,758,120 shares. The largest 10 holders included ORBIMED ADVISORS LLC, Novo A/S, FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, JENNISON ASSOCIATES LLC, Rock Springs Capital Management LP, SCOPIA CAPITAL MANAGEMENT LP, CREDIT SUISSE AG/, Alyeska Investment Group, L.P., and Allianz Asset Management AG. This page lists 31 institutional shareholders reporting positions in this security for the Q1 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2016 vs Q4 2025 Across Filers

Q4 2025 holders
125
Q1 2016 holders
31
Holder diff
-94
Investor Q4 2025 Shares Q1 2016 Shares Share Diff Share Chg % Q4 2025 Value $ Q1 2016 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .